Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: A clinican’s guide
SV Porceddu(Princess Alexandra Hospital), WB Coman, Adam Stoneley, Michael B. Foote(Memorial Sloan Kettering Cancer Center), Liz Kenny(Palo Alto University), Elizabeth Burmeister, B. El Hawwari(Royal Prince Alfred Hospital), Michael Poulsen(Mater Health Services), Chris Milross(Chris O’Brien Lifehouse), Mark Sidhom(Liverpool Hospital)
Cited by 2
Related Papers
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
|Journal of Clinical Oncology|2010|372
Use of Artificial Intelligence Chatbots for Cancer Treatment Information
|JAMA Oncology|2023|220
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses
|Nature Biotechnology|2023|192
Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy
|British Journal of Cancer|2010|139